Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Mason

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Vaccine|April 22, 2008
Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation systemDouglas G Widman, Tomohiro Ishikawa, Rafik Fayzulin, et al.
Journal of Virology|October 14, 2004
trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectorsFrank Scholle, Yvette A Girard, Qizu Zhao, et al.
Virology|March 27, 2007
Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivoShannan L Rossi, Rafik Fayzulin, Nathan Dewsbury, et al.
Virology|February 10, 2007
Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: characterization of a temperature-sensitive mutation in NS1Ryosuke Suzuki, Luana de Borba, Claudia N Duarte dos Santos, et al.
Journal of Virology|August 30, 2013
TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidateJingya Xia, Evandro R Winkelmann, Summer R Gorder, et al.
Virology|November 12, 2013
Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicityGiulietta Maruggi, Christine A Shaw, Gillis R Otten, et al.
Journal of Virology|December 4, 2003
Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virusJuan M Pacheco, Tina M Henry, Vivian K O'Donnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2011
Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitisJennifer L Uhrlaub, James D Brien, Douglas G Widman, et al.
Journal of Virology|October 5, 2007
Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cellsMaria Carlan Silva, Antonieta Guerrero-Plata, Felicia D Gilfoy, et al.
Vaccine|July 29, 2009
RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamstersDouglas G Widman, Tomohiro Ishikawa, Evandro R Winkelmann, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Vaccine|April 22, 2008
Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation systemDouglas G Widman, Tomohiro Ishikawa, Rafik Fayzulin, et al.
Journal of Virology|October 14, 2004
trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectorsFrank Scholle, Yvette A Girard, Qizu Zhao, et al.
Virology|March 27, 2007
Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivoShannan L Rossi, Rafik Fayzulin, Nathan Dewsbury, et al.
Virology|February 10, 2007
Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: characterization of a temperature-sensitive mutation in NS1Ryosuke Suzuki, Luana de Borba, Claudia N Duarte dos Santos, et al.
Journal of Virology|August 30, 2013
TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidateJingya Xia, Evandro R Winkelmann, Summer R Gorder, et al.
Virology|November 12, 2013
Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicityGiulietta Maruggi, Christine A Shaw, Gillis R Otten, et al.
Journal of Virology|December 4, 2003
Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virusJuan M Pacheco, Tina M Henry, Vivian K O'Donnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2011
Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitisJennifer L Uhrlaub, James D Brien, Douglas G Widman, et al.
Journal of Virology|October 5, 2007
Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cellsMaria Carlan Silva, Antonieta Guerrero-Plata, Felicia D Gilfoy, et al.
Vaccine|July 29, 2009
RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamstersDouglas G Widman, Tomohiro Ishikawa, Evandro R Winkelmann, et al.
Pageof 7